Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$76.42
-0.2%
$76.50
$58.93
$88.28
$44.91B1.115.28 million shs4.87 million shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$30.94
+2.2%
$29.48
$23.69
$31.72
$13.26B0.69820,824 shs949,146 shs
STERIS plc stock logo
STE
STERIS
$223.90
+0.6%
$238.49
$200.98
$252.79
$21.90B0.92566,719 shs818,037 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$96.67
+4.4%
$93.26
$89.22
$116.71
$18.32B0.711.83 million shs1.86 million shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
+0.16%-2.27%+3.76%+8.54%-11.49%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
+0.38%+0.67%+5.06%+15.50%+6.95%
STERIS plc stock logo
STE
STERIS
-1.27%-1.36%-5.48%-0.16%-0.78%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
-0.48%-1.13%+1.66%-4.90%-16.08%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
4.3683 of 5 stars
2.23.00.04.02.82.52.5
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
3.1996 of 5 stars
1.03.02.50.03.20.04.4
STERIS plc stock logo
STE
STERIS
4.8419 of 5 stars
3.43.04.23.82.62.51.3
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.954 of 5 stars
3.25.02.53.73.22.52.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
2.48
Hold$81.006.00% Upside
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.00
Hold$28.00-9.49% Downside
STERIS plc stock logo
STE
STERIS
2.75
Moderate Buy$270.3320.74% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.35
Hold$111.3915.23% Upside

Current Analyst Ratings Breakdown

Latest STE, EW, ZBH, and SNN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/22/2025
STERIS plc stock logo
STE
STERIS
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$277.00 ➝ $288.00
7/16/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$85.00 ➝ $87.00
7/15/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$75.00 ➝ $81.00
7/15/2025
STERIS plc stock logo
STE
STERIS
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$260.00 ➝ $276.00
7/15/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$135.00
7/10/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/8/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$73.00 ➝ $77.00
7/8/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetIn-Line ➝ In-Line$102.00 ➝ $96.00
6/2/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Dbs Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/29/2025
STERIS plc stock logo
STE
STERIS
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$263.00
5/22/2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$84.00 ➝ $95.00
(Data available from 7/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$5.44B8.24$2.73 per share28.04$17.06 per share4.48
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$5.81B2.33$3.23 per share9.59$12.04 per share2.57
STERIS plc stock logo
STE
STERIS
$5.46B4.03$14.33 per share15.62$67.33 per share3.33
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.68B2.49$13.77 per share7.02$62.67 per share1.54
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$4.17B$7.0010.9227.793.8475.48%16.62%12.64%7/24/2025 (Estimated)
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$412M$2.1614.3215.470.93N/AN/AN/A8/5/2025 (Estimated)
STERIS plc stock logo
STE
STERIS
$614.64M$6.2036.1122.55N/A11.26%14.21%9.13%8/5/2025 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.5221.3910.902.1611.86%12.73%7.34%8/7/2025 (Estimated)

Latest STE, EW, ZBH, and SNN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.99N/AN/AN/A$2.06 billionN/A
8/5/2025Q1 2026
STERIS plc stock logo
STE
STERIS
$2.32N/AN/AN/A$1.36 billionN/A
7/24/2025Q2 2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.62N/AN/AN/A$1.49 billionN/A
5/14/2025Q4 2025
STERIS plc stock logo
STE
STERIS
$2.59$2.74+$0.15$1.47$1.47 billion$1.48 billion
5/5/2025Q1 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.77$1.81+$0.04$0.91$1.89 billion$1.91 billion
4/23/2025Q1 2025
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.60$0.64+$0.04$0.61$1.40 billion$1.41 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.892.88%N/A41.20%N/A
STERIS plc stock logo
STE
STERIS
$2.281.02%N/A36.77%20 Years
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.960.99%N/A21.24%N/A

Latest STE, EW, ZBH, and SNN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/30/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.241.03%6/26/20256/26/20257/31/2025
5/7/2025
STERIS plc stock logo
STE
STERIS
quarterly$0.571.01%6/10/20256/10/20256/26/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.06
4.45
3.66
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.62
2.89
1.33
STERIS plc stock logo
STE
STERIS
0.29
1.96
1.39
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.53
2.44
1.46

Institutional Ownership

CompanyInstitutional Ownership
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
79.46%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%
STERIS plc stock logo
STE
STERIS
94.69%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.34%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
1.00%
STERIS plc stock logo
STE
STERIS
1.07%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
15,800586.60 million584.61 millionOptionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
17,349437.98 million433.60 millionOptionable
STERIS plc stock logo
STE
STERIS
17,78798.37 million97.32 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
17,000197.85 million196.46 millionOptionable

Recent News About These Companies

Zimmer Biomet to pay $177M for orthopedic robotics company
Zimmer Biomet (NYSE:ZBH) Upgraded at Roth Capital
Roth MKM upgrades Zimmer Biomet Holdings (ZBH) to a Buy
Zimmer Biomet wins price target raise at Roth

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$76.42 -0.15 (-0.19%)
Closing price 03:58 PM Eastern
Extended Trading
$76.25 -0.17 (-0.22%)
As of 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$30.94 +0.66 (+2.16%)
Closing price 03:58 PM Eastern
Extended Trading
$30.92 -0.01 (-0.03%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

STERIS stock logo

STERIS NYSE:STE

$223.90 +1.25 (+0.56%)
Closing price 03:58 PM Eastern
Extended Trading
$223.72 -0.19 (-0.08%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$96.67 +4.08 (+4.40%)
Closing price 03:58 PM Eastern
Extended Trading
$96.26 -0.41 (-0.43%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.